Hudson Bay Capital Management »

BioCryst Pharmaceuticals shares owned by Hudson Bay Capital Management

Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by Hudson Bay Capital Management from 13F filings

Historical chart of Hudson Bay Capital Management investment in BioCryst Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including BioCryst Pharmaceuticals held by Hudson Bay Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioCryst Pharmaceuticals by Hudson Bay Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $779k 130k 5.99
2023-09-30 $460k 65k 7.08
2023-06-30 $456k 65k 7.04
2023-03-31 $355k 43k 8.34
2022-12-31 $287k 25k 11.48
2019-03-31 $1.1M 140k 8.14
2018-12-31 $1.0M 130k 8.07
2018-09-30 $1.7M 220k 7.63
2018-06-30 $1.7M 300k 5.73
2018-03-31 $2.7M 560k 4.77